Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05849441 · ClinicalTrials.gov registry record · NA

Mindfulness Program for Adolescents With 22q11DS

A NA study of 22Q11 Deletion Syndrome, sponsored by Innovation Research & Training.

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT05849441 is a NA study of 22Q11 Deletion Syndrome that has completed, run by Innovation Research & Training. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05849441, a NA study of 22Q11 Deletion Syndrome, has completed, sponsored by Innovation Research & Training.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the effectiveness of the Aware Program, an online mindfulness education program, with adolescents with 22q11DS and their parents.

Conditions Studied

Interventions

  • BEHAVIORAL Aware Program

Study Locations (1)

North Carolina

  • innovation Research & Training - Durham

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2023-12-18
Est. Completion 2024-08-17
Phase NA

Sponsor

Innovation Research & Training

14 total trials

What the Registry Record Tells You About NCT05849441

The ClinicalTrials.gov registry entry for NCT05849441 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovation Research & Training, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with 22Q11 Deletion Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Aware Program is the first listed.

NCT05849441 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05849441 about?

NCT05849441 is a clinical study titled "Mindfulness Program for Adolescents With 22q11DS". The goal of this study is to evaluate the effectiveness of the Aware Program, an online mindfulness education program, with adolescents with 22q11DS and their parents.

What is the current status of trial NCT05849441?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2023-12-18. Estimated completion is 2024-08-17.

What conditions does trial NCT05849441 study?

This clinical trial studies the following conditions: 22Q11 Deletion Syndrome.

What interventions are being tested in trial NCT05849441?

The interventions under investigation include: Aware Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05849441?

This trial is sponsored by Innovation Research & Training, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05849441 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.